A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors-Reference-Cited by-同舟云学术

A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors

Published:2003-07 Issue:7-8 Volume:38 Page:703-710
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Michaux Catherine,Dogné Jean-Michel,Rolin Stéphanie,Masereel Bernard,Wouters Johan,Durant François

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference33 articles.

1. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904

2. Thromboxane A2and related prostaglandins in airways

3. The biochemical pharmacology of thromboxane synthase inhibition in man.

4. Thromboxane Synthase Inhibition Combined with Thromboxane Receptor Blockade: A Step Forward in Antithrombotic Strategy?

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Modeling Studies on Cytochrome P450-mediated Drug Metabolism;Current Drug Metabolism;2021-08

2. Synthesis and evaluation of α-glucosidase inhibitory activity of sulfonylurea derivatives;Zeitschrift für Naturforschung B;2021-03-04

3. Human cytochrome P450 enzymes 5–51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition – toxic effects and benefits;Drug Metabolism Reviews;2018-07-03

4. One-Pot Synthesis of N-Monosubstituted Ureas from Nitriles via Tiemann Rearrangement;Synlett;2015-07-20

5. Synthesis of Novel 1-(4-Substituted pyridine-3-sulfonyl)-3-phenylureas with Potential Anticancer Activity;Molecules;2015-07-01